Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivoTatsuo Ito, Kenji Shimizu, Mamoru Ouchida et al.|Cancer Letters|2004Cited by 103
Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcomaYuki Morimoto, Hajime Inoue, Toshifumi Ozaki et al.|Cancer|2003Cited by 99
Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue SarcomasTsuyoshi Sasaki, Toshiyoshi Fujiwara, Ryosuke Yoshida et al.|Clinical Cancer Research|2011Cited by 52
SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complexTatsuo Ito, Kenji Shimizu, Mamoru Ouchida et al.|Laboratory Investigation|2004Cited by 51
MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4)Satoru Itani, Toshifumi Ozaki, Toshiyuki Kunisada et al.|Journal of Cancer Research and Clinical Oncology|2012Cited by 50